Tilray Brands, Inc. (NASDAQ:TLRY), backed by significant analyst-implied upside, ranks among the overlooked penny stocks to ...
There are much better ways to spend $5.
Zacks Investment Research on MSN
TLRY plans strategic medical cannabis expansion: Time to buy or sell?
Tilray Brands TLRY recently announced the acquisition of HelloMD, a Canadian virtual healthcare platform focused on medical ...
Tilray Brands is back in focus as analysts reset their thinking on where the stock might be headed, with some firms cutting price targets in both US$ and C$ while others keep their fair value view ...
CHONGQING, CHINA - APRIL 6: In this photo illustration, the Tilray Brands logo is displayed on a smartphone screen, with the company's stock market performance and candlestick charts visible in the ...
Tilray Brands (NASDAQ: TLRY) has witnessed a considerable surge, rising nearly 200% from $0.42 in early July to its present price of $1.24. This increase is largely attributed to the Trump ...
Detailed price information for Tilray Brands Inc (TLRY-Q) from The Globe and Mail including charting and trades.
Shares of Tilray Brands TLRY, one of the most well-known players in the cannabis space, have been declining steadily over the past month. This downside can be attributed to the U.S. legislation passed ...
Tilray Brands TLRY posted its second-quarter fiscal 2026 results last Thursday after the closing bell. The company’s net revenues reached a record $217.5 million, up 3% on a year-over-year basis and ...
Tilray Brands Inc (NASDAQ: TLRY) shares are trading lower Friday morning, continuing a downward trend after the company confirmed it will implement a 1-for-10 reverse stock split. What To Know: The ...
What To Know: Cannabis stocks rallied last week following a report suggesting that President Donald Trump is expected to reclassify marijuana as a Schedule III drug. The proposed change would place ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results